ELAPRASE (Shire US Manufacturing Inc.)


Welcome to the PulseAid listing for the ELAPRASE drug offered from Shire US Manufacturing Inc.. This alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Shire US Manufacturing Inc.
NON-PROPRIETARY NAME: idursulfase
SUBSTANCE NAME: IDURSULFASE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION, CONCENTRATE
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2006-07-24
END MARKETING DATE: 0000-00-00


ELAPRASE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionELAPRASE from Shire US Manufacturing Inc.
LABELER NAME: Shire US Manufacturing Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6(mg/3mL)
START MARKETING DATE: 2006-07-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54092-700_2db83830-65c2-6b1e-e054-00144ff8d46c
PRODUCT NDC: 54092-700
APPLICATION NUMBER: BLA125151

Other IDURSULFASE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Shire US Manufacturing Inc.ELAPRASE